Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001494650-25-000072
Filing Date
2025-05-14
Accepted
2025-05-14 16:11:37
Documents
79
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q optn-20250331.htm   iXBRL 10-Q 809905
2 EX-31.1 optn5-13x202510xqex3111.htm EX-31.1 8399
3 EX-31.2 optn5-13x202510xqex3121.htm EX-31.2 8290
4 EX-32.1 optn5-13x202510xqex3211.htm EX-32.1 5216
5 EX-32.2 optn5-13x202510xqex3221.htm EX-32.2 5091
11 optn-20250331_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-25-000072.txt   5577020

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20250331.xsd EX-101.SCH 46248
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT optn-20250331_cal.xml EX-101.CAL 48639
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT optn-20250331_def.xml EX-101.DEF 236587
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20250331_lab.xml EX-101.LAB 586742
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20250331_pre.xml EX-101.PRE 420526
82 EXTRACTED XBRL INSTANCE DOCUMENT optn-20250331_htm.xml XML 618688
Mailing Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067
Business Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

EIN.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38241 | Film No.: 25945606
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)